Moreover, everolimus induced apoptosis by decreasing Bcl-2, phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), and mTOR expression levels in breast cancer cells [40]. The gene discussed is BCL2; the disease is breast carcinoma.